As previous study reported, YTHDF2 induced the targeted degradation of the tumor suppressor to accelerate tumor progression, while this regulation was dependent on METTL3‐medicated m6A modification [5, 36, 37]. This evidence concerns the gene METTL3 and neoplasm.